Cytokines and nitric oxide in islet inflammation and diabetes (43950D)

Experimental Biology and Medicine

Volumn 211, Issue 1, 1996, Pages 24-32

  Mcdaniel, Michael L ^a   Kwon, Guim ^a   Hill, Jeanette R ^a   Marshall, Connie A ^a   Corbett, John A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARACHIDONIC ACID METABOLISM; AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; DIABETES MELLITUS; INFLAMMATION; INSULIN RELEASE; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE;

ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-1; ISLETS OF LANGERHANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0030030057     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633, 1965.
2. Bottazzo GF, Dean BM, McNally JM, MacDay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985.
3. Sibley RK, Sutherland DE, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985.
4. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903, 1992.
5. Corbett JA, Kwon G, Turk J, McDaniel ML. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-13770, 1993.
6. Mandrup-Poulsen T, Bendtzen K, Nielsen H, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424-429, 1985.
7. Spinas GA, Mandrup-Poulsen T, Molvig J, Baek L, Bendtzen K, Dinarello CA, Nerup J. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol 113:551-558, 1986.
8. Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML. Interleukin 1 is a potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 36:963-970, 1987.
9. Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86:856-363, 1990.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
11. Marietta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 268:12231-12234, 1993.
12. Corbett JA, Tilton RG, Chang K, Hasan K, Ido Y, Wang JL, Sweetland M, Lancaster J, Williamson JR, McDaniel ML. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992.
13. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible isoform of nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-125, 1993.
14. Forstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Biochem Pharmacol 42:1849-1857, 1991.
15. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
16. Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF, McDaniel ML. Nitric oxide modulates IL-1β-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15:145-153, 1993.
17. Bredt DS, Synder SH. Nitric oxide, a novel neuronal messenger. Cell 8:3-11, 1992.
18. Lancaster JR Jr. Nitric oxide in cells. Am Sci 80:248-259, 1992.
19. Southern D, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generation mechanism. FEBS Lett 276:42-44, 1990.
20. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173, 1991.
21. Corbett JA, Lancaster JR, Sweetland MA, McDaniel ML. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 266:21351-21354, 1991.
22. Corbett JA, Sweetland MA, Wang J-L, Lancaster JR, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90:1731-1735, 1993.
23. Corbett JA, Wang J, Hughes J, Wolf B, Sweetland M, Lancaster JR, McDaniel ML. Nitric oxide and cyclic GMP formation induced by interleukin 1β in islets of Langerhans. Biochem J 287:229-235, 1992.
24. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, McDaniel ML. IL-1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. J Clin Invest 90:2384-2391, 1992.
25. Corbett JA, Sweetland MA, Lancaster JR, McDaniel ML. A 1 hour pulse with IL-1β induces the formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: Evidence for a tyrosine kinase signaling mechanism. FASEB J 7:369-374, 1993.
26. Corbett JA, McDaniel ML. Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299:719-724, 1994.
27. Corbett JA, Kwon G, Misko TP, Rodi CP, McDaniel ML. Tyrosine kinase involvement in IL-1β-induced expression of iNOS by β-cells purified from islets of Langerhans. Am J Physiol 267(Cell Physiol 36):C48-C54, 1994.
28. Corbett JA, McDaniel ML. Intraislet release of interleukin 1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995.
29. Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB rats. Diabetes 34:197-199, 1985.
30. Wright JR, Lefkowith JB, Schreiner G, Lacy PE. Essential fatty induced diabetes in CD-1 mice. Proc Natl Acad Sci USA 85:6137-6141, 1988.
31. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080-5085, 1993.
32. Ankarcrona M, Dypbukt J, Brune B, Nicotera P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213:172-177, 1994.
33. Delaney CA, Green MHL, Lowe JE, Green IC. Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett 3:291-295, 1993.
34. 2 accumulation by isolated pancreatic islets. Diabetes 38:1251-1257, 1989.
35. 2+ in glucose-induced insulin secretion by pancreatic islets. Prog Lipid Res 26:125-183, 1987.
36. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 55:69-102, 1986.
37. Bull HA, Dowd PM. Prostaglandin synthetase, interleukin 1 and inflammation in the skin. Prostaglandins Leukot Essent Fatty Acids 46:167-173, 1991.
38. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244, 1993.
39. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 93:1940-1947, 1994.
40. 2 release from the hypothalamus. Proc Natl Acad Sci USA 89:11543-11546, 1992.
41. Franchi AM, Chaud M, Rettori V, Suburo A, McCann SM, Gimeno M. Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc Natl Acad Sci USA 91:539-543, 1994.